Autoimmune Encephalitis, Paraneoplastic Neurological Syndrome
Conditions
Brief summary
This study aims to provide an estimate of the incidence of paraneoplastic neurological syndromes and autoimmune encephalitides in France between the years 2016 and 2018. The study will describe the incidence of antibody subtypes and regional variations.
Interventions
None listed
Sponsors
Hospices Civils de Lyon
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
\- Clinical diagnosis of Paraneoplastic Neurological Syndrome (PNS) or Autoimmune Encephalitis (AE) made by the referring physician to the national center for PNS and AE in Lyon between 2016 and 2018
Exclusion criteria
* Data on location of diagnosis missing * Patients diagnosed out of the mainland French territory * Patients for whom insufficient data was available
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence and prevalence of diagnosed Paraneoplastic Neurological Syndromes (PNS) and Autoimmune Encephalitis (AE) between 2016 and 2018. | 3 years | Comparison between general population of the French counties and the cohort of PNS to calculate incidence and prevalence. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Location (city) of diagnosis | 1 hour | Name of city where the diagnosis of Paraneoplastic Neurological Syndromes (PNS) or Autoimmune Encephalitis (AE) was made. |
| French general population of each counties | 3 years | Person years for each region |
Countries
France
Contacts
Primary ContactGéraldine Picard
Backup ContactJérôme Honnorat
Outcome results
None listed